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ABSTRACT The absolute (standard) binding free energy of eight FK506-related ligands to FKBP12 is calculated using free
energy perturbation molecular dynamics (FEP/MD) simulations with explicit solvent. A number of features are implemented to
improve theaccuracy andenhance the convergenceof the calculations. First, the absolute binding freeenergy is decomposed into
sequential steps during which the ligand-surrounding interactions as well as various biasing potentials restraining the translation,
orientation, and conformation of the ligand are turned ‘‘on’’ and ‘‘off.’’ Second, sampling of the ligand conformation is enforced by a
restraining potential based on the root mean-square deviation relative to the bound state conformation. The effect of all the
restraining potentials is rigorously unbiased, and it is shown explicitly that the ﬁnal results are independent of all artiﬁcial restraints.
Third, the repulsive and dispersive free energy contribution arising from the Lennard-Jones interactions of the ligand with its
surrounding (protein and solvent) is calculated using the Weeks-Chandler-Andersen separation. This separation also improves
convergenceof theFEP/MDcalculations. Fourth, to decrease the computational cost, only a small number of atoms in thevicinity of
thebindingsite are simulatedexplicitly,while all the inﬂuenceof the remainingatoms is incorporated implicitly using thegeneralized
solvent boundary potential (GSBP)method.WithGSBP, the size of the simulated FKBP12/ligand systems is signiﬁcantly reduced,
from;25,000 to 2500. The computations are very efﬁcient and the statistical error is small (;1 kcal/mol). The calculated binding
freeenergies aregenerally in goodagreementwith available experimental data andprevious calculations (within;2kcal/mol). The
present results indicate that a strategy based on FEP/MD simulations of a reduced GSBP atomic model sampled with
conformational, translational, and orientational restraining potentials can be computationally inexpensive and accurate.
INTRODUCTION
Molecular recognition phenomena involving the association
of ligands to macromolecules with high afﬁnity and spec-
iﬁcity play a key role in biology (1–3). Although the fun-
damental microscopic interactions giving rise to bimolecular
association are relatively well understood, designing com-
putational schemes to accurately calculate absolute binding
free energies remains very challenging. Computational ap-
proaches currently used for screening large databases of
compounds to identify potential lead drug molecules must
rely on very simpliﬁed approximations to achieve the needed
computational efﬁciency (4). Nonetheless, the calculated
free energies ought to be very accurate to have any predictive
value. Furthermore, the importance of solvation in scoring
ligands in molecular docking has been stressed previously
(5).
In principle, free energy perturbation molecular dynamics
(FEP/MD) simulations based on atomic models are the most
powerful and promising approaches to estimate binding free
energies of ligands to macromolecules (6–11). Indeed, test
calculations have shown that FEP/MD simulations can be
more reliable than simpler scoring schemes to compute rela-
tive binding afﬁnities in important biological systems (12,13),
and that it can naturally handle the inﬂuence of solvent and
dynamic ﬂexibility (14). There is a hope that calculations
based on FEP/MD simulations for protein-ligand interac-
tions could become a useful tool in drug discovery and
optimization (15–22). Nonetheless, despite outstanding de-
velopments in simulation methodologies (23), carrying out
FEP/MD calculations of large macromolecular assemblies
surrounded by explicit solvent molecules often remains
computationally prohibitive. For this reason, it is necessary
to seek ways to decrease the computational cost of FEP/MD
calculations while keeping them accurate.
To simulate accurately the behavior of molecules, one
must be able to account for the thermal ﬂuctuations and
the environment-mediated interactions arising in diverse
and complex systems (e.g., a protein binding site or bulk
solution). In FEP/MD simulations, the computational cost is
generally dominated by the treatment of solvent molecules.
Computational approaches at different level of complexity
and sophistication have been used to describe the inﬂuence
of solvent on biomolecular systems (24). Those range from
MD simulations based on all-atom models in which the
solvent is treated explicitly (10,25), to Poisson-Boltzmann
(PB) continuum electrostatic models in which the inﬂuence
of the solvent is incorporated implicitly (24,26). There are also
semianalytical approximations to continuum electrostatics,
such as generalized Born (27–31), as well as empirical treat-
ments based on solvent-exposed surface area (32–40). How-
ever, even though such approximations are computationally
convenient, they are often of unknown validity when they
are applied to a new situation.
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An intermediate approach, which combines some aspects
of both explicit and implicit solvent treatments (41–43), con-
sists in simulating a small number of explicit solvent mole-
cules in the vicinity of a region of interest, while representing
the inﬂuence of the surrounding solvent with an effective
solvent-boundary potential (41–50). Such an approximation
is an attractive strategy to decrease the computational cost of
MD/FEP computations because binding speciﬁcity is often
dominated by local interactions in the vicinity of the ligand
while the remote regions of the receptor contribute only in an
average manner. The method used in this study is called the
generalized solvent boundary potential (GSBP) (43). GSBP
includes both the solvent-shielded static ﬁeld from the
distant atoms of the macromolecule and the reaction ﬁeld
from the dielectric response of the solvent acting on the
atoms of the simulation region. GSBP is a generalization of
spherical solvent boundary potential, which was designed to
simulate a solute in bulk water (41). In the GSBP method, all
atoms in the inner region belonging to ligand, macromole-
cule, or solvent can undergo explicit dynamics, whereas the
inﬂuence of the macromolecular and solvent atoms outside
the inner region are included implicitly.
It is also possible to reduce the computational cost of FEP/
MD simulations and even improve their accuracy by using
a number of additional features. For example, the Weeks
Chandler Andersen (WCA) separation of the Lennard-Jones
potential can be used to efﬁciently calculate the free energy
contribution arising from the repulsive and dispersive inter-
actions (51,52). Furthermore, biasing potentials restraining
the translation, orientation, and conformation of the ligand
can help enhance the convergence of the calculations (17,21,
22,53,54). Such a procedure can provide correct results as
long as the effect of all the restraining potentials is rigorously
taken into account and unbiased. Combining these elements
yields the present computational strategy, which consists in
FEP/MD simulations of a reduced GSBP atomic model with
enhanced sampling using conformational, translational, and
orientational restraining potentials.
In this study, the absolute (standard) binding free energies
of eight FK506-related ligands to FKBP12 (FK506 Binding
Protein) are calculated using FEP/MDsimulationswithGSBP
to explore the practical feasibility of such a computational
strategy. FKBP12 is a rotamase catalyzing the cis-trans
isomerization of peptidyl-prolyl bonds (55). FK506 is a key
drug used for immunosuppression in organ transplant.
It binds strongly to FKBP12 (56) and the FKBP12/FK506
complex, in turn, binds and inhibits calcineurin, thus block-
ing the signal transduction pathway for the activation of
T-cells (57,58). In addition to its obvious importance as a
pharmacological target, FKBP12 was chosen in this study
for three main reasons. First, crystal structures of FKBP12 in
complex with several ligands are available (59–61). Second,
the binding constants of those FK506-related ligands with
FKBP12 have been experimentally determined (60). Third,
this system serves as a rich platform to test and validate dif-
ferent computational strategies to estimate binding free ener-
gies (62–65). This study is part of an ongoing collaborative
effort involving two other groups (Pande (63) and J. A.
McCammon, personal communication, 2005) with the goal
of comparing the results of calculations based on different
treatments and approximations but using the same force ﬁeld
(AMBER). Pande and co-workers (63) and Shirts (64)
carried out extensive all-atom free energy perturbation (FEP)
molecular dynamics (MD) simulations.With the same system,
J. M. Swanson and J. A. McCammon (personal communica-
tion, 2005) used molecular mechanics/Poisson-Boltzmann-
and-surface-area (MM-PBSA), a popular approach that relies
on a mixed scheme combining conﬁgurations sampled from
molecular dynamics (MD) simulations with explicit solvent,
with free energy estimators based on an implicit continuum
solvent model (66).
In the next two sections, the theoretical formulation and
the computational details are given. Then, all the results of
the computations are presented and discussed in the follow-
ing section. The article ends with a brief conclusion sum-
marizing the main points.
METHODS
Theoretical formulation
The theoretical formulation for the equilibrium binding constant used here
was previously elaborated in Deng and Roux (52). Brieﬂy, the equilibrium
binding constant Kb for the process corresponding to the association of a
ligand L to a protein P, L 1 P  LP, can be expressed as
Kb ¼
R
site
dðLÞ R dðXÞebUR
bulk
dðLÞdðrL  rÞ
R
dðXÞebU; (1)
where L represents the coordinates of the ligand (only a single ligand needs
to be considered at low concentration), X represents the coordinate of the
solvent and the protein, b [ 1/kBT, U is the total potential energy of the
system, rL is the position of the center-of-mass of the ligand, and r* is some
arbitrary position (far away) in the bulk solution. The subscripts site and bulk
indicate that the integrals include only conﬁgurations in which the ligand is
in the binding site or in the bulk solution, respectively. Eq. 1 can be related to
the double decoupling method (17,21), though the derivation in Deng and
Roux (52) proceeds from population conﬁgurational ensemble averages
rather than the traditional treatment that consists in equating the chemical
potentials of the three species, L, R, and LR. In particular, it should be noted
that, Kb has dimension of volume because of the d-function d(rL–r*) in the
denominator. This d-function arises from the translational invariance of the
ligand in the bulk volume (see (52)).
For computational convenience, the reversible work for the entire
association/dissociation process is decomposed into eight sequential steps
during which the interaction of the ligand with its surrounding (protein and
solvent) as well as various restraining potentials are turned ‘‘on’’ and ‘‘off’’
(see Appendix A). Various potentials restraining the conformation, position,
and orientation of the ligand are used throughout the step-by-step process.
Those are designed to reduce the conformational sampling workload of
the free energy simulations by biasing the ligand to be near its bound
conﬁguration (conformation, position, and orientation) as it becomes com-
pletely decoupled from its surrounding. This approach has the advantage of
focusing the sampling on the most relevant conformations, though it is
essential that the biasing effect of the restraining potentials be rigorously
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handled and that the ﬁnal result from the computation be independent of the
restraints. The usage of biasing restraints in computations of binding free
energies goes back to early work by Hermans and Subramaniam (67), with a
number of recent variants (21,22,52–54).
The translational and orientational restraining potentials are constructed
from three point-positions deﬁned in the protein (Pc, P1, and P2) and three
point-positions deﬁned in the ligand (Lc, L1, and L2) (Fig. 3). Speciﬁcally, Pc
is the center-of-mass of the protein residues forming the binding site, and Lc
is the center-of-mass of the ligand. P1 and P2 are the center-of-mass of two
groups of atoms in the protein, while L1 and L2 are the center-of-mass of two
groups of atoms in the ligand. The choice of the six reference point-positions
is more or less arbitrary, as long as they are not co-linear and allow us to
deﬁne the orientation of the ligand relative to the protein. The translational
restraint is deﬁned as ut ¼ 1/2[kt(rL  r0)21 ka(uL  u0)2 1 ka(fL  f0)2],
where rL is the distance Pc  Lc, uL is the angle P1  Pc  Lc, and fL is the
dihedral angle P2  P1  Pc  Lc; kt and ka are the force constants, and r0,
u0, andf0 are the average values of the fully interacting ligand in the binding
site taken as a reference. Similarly, the orientational restraining potential is
deﬁned as ur ¼ 1/2[ka(aL  a0)21 ka(bL  b0)21 ka(gL  g0)2], where the
angle aL (Pc  Lc  L1), the dihedral angle bL (P1  Pc  Lc  L1), and the
dihedral angle gL (Pc  Lc  L1  L2) are three angles deﬁning the rigid
body rotation; ka is the force constant, and a0, b0, and g0 are the reference
values taken from the fully interacting ligand in the binding site. Generally,
the reference values and the force constants are taken from an average based
on an unbiased simulation of the fully interacting ligand in the binding site.
The magnitude of the force constants is estimated from the ﬂuctuations of its
associated coordinates as kx  kBT/ÆDx2æ. This has been shown to yield the
optimal biasing in free energy perturbations (53). The conformational
restraining potential uc is also constructed as a quadratic function, uc ¼
kc(z[L;Lref])
2, where kc is a force constant, and z is the root mean-square
deviation (RMSD) of the ligand coordinates L relative to the average
structure of the fully interacting ligand in the binding site Lref, taken as a
reference structure.
With these deﬁnitions, the sequential steps corresponding to the
dissociation process with the fully interacting ligand in the protein binding
site as initial state are (see also Table A1 in Appendix A):
1. A potential uc is applied to the fully interacting ligand (U1) in the
binding site to maintain its conformation near the average bound state.
2. A potential ut is applied to the center-of-mass of the fully interacting
ligand (U1) restrained by uc to maintain its relative position in the
binding site.
3. A potential ur is applied to the fully interacting ligand (U1), restrained
by uc and ut, to maintain its relative orientation in the binding site.
4. The interactions of the ligand, restrained by uc, ut, and ur, with the
binding site are turned off (decoupling: U1/ U0).
5. The potential ur applied to the decoupled ligand (U0), restrained by uc
and ut, is released.
6. The restraining potential ut applied to the decoupled ligand (U0),
restrained by uc, is released.
7. The interaction of the ligand, restrained by uc, with the surrounding bulk
solution is turned on (coupling: U0/ U1).
8. The potential uc applied to the fully interacting ligand in the bulk
solution (U1) is ﬁnally released.
As shown in Appendix A, the standard binding free energy DGbind is
given by
DGbind ¼ DGsitec  DGsitet  DGsiter 1DGsiteint  kBT lnðFrÞ
 kBT lnðFtCÞ  DGbulkint 1DGbulkc ; (2)
where DGsitec , DG
site
t , DG
site
r , DGsiteint , kBT ln Fr, kBT ln(FtC), DGbulkint , and
DGbulkc correspond to the reversible work done in Steps 1–8, respectively.
Since the ligand is decoupled from its environment in Steps 5 and 6, the
factor Fr can be evaluated as a numerical integral over three rotation angles,
and the factor Ft can be evaluated as a numerical integral over the translation
of the ligand center-of-mass in three-dimensional space. The constant C
insures conversion to the standard state concentration (¼ 1 M or 1/1661
A˚3). All the remaining DG contributions must be calculated using FEP/MD
simulations. It is useful to combine the corresponding contributions in Eq. 2
and express the standard binding free energy as
DGbind ¼ DDGint1DDGc1DDGt1DDGr; (3)
where DDGint ¼ DGsiteint  DGbulkint corresponds to the free energy contribu-
tion arising from the interactions of the ligand with its surrounding
(bulk and/or protein), while DDGc ¼ DGsitec 1DGbulkc , DDGt ¼ DGsitet
kBT lnðFtCÞ, and DDGr ¼ DGsiter  kBT lnFr correspond to the con-
formational, translational, and orientational restriction of the ligand upon
binding, respectively. Equation 3 makes the interpretation of each contri-
bution intuitively clear (see below). Lastly, if the ligand has symmetry and
can bind in a number of equivalent ways, it is necessary to include the effect
of the symmetry factor n as  kBT ln(n).
PRACTICALITIES
Translational and orientational contributions
It is customary to describe bimolecular binding as a process
in which a ligand free in solution loses translational and
orientational degrees of freedom, as it associates with the
protein. The unfavorable contribution to the standard binding
free energy caused by the loss of freedom is compensated
for, as the ligand gains favorable interactions with proteins.
In this regard, it is informative to consider DDGt, the free
energy contribution associated with the translation of the
ligand, obtained by combining DGsitet and the factor Ft,
e
bDDG+t ¼ C3 ebDGsitet 3Ft
¼ C3
R
site
dðLÞ R dXeb½U11uc R
site
dðLÞ R dXeb½U11uc1ut 3
Z
drLe
butðrLÞ
¼ C3
R
site
drLP
site
t ðrLÞR
site
drLP
site
t ðrLÞebutðrLÞ
3
Z
drLe
butðrLÞ; (4)
where Psitet is the probability distribution of ligand position in
the binding site. If the translational restraining potential
ut(rL) is strong and centered on rm—the most probable posi-
tion of the ligand center-of-mass in the binding site (the maxi-
mum of Psitet )—the probability distribution with the restraint
is sharply peaked at rm,
e
butðrLÞR
site
drLe
butðrLÞ  dðrL  rmÞ; (5)
and the translational contribution is
e
bDDG+t  C3
Z
site
drL
P
site
t ðrLÞ
P
site
t ðrmÞ
¼ CDV; (6)
where DV is an effective accessible volume for the center-of-
mass of the ligand in the binding site. This volume, which is
evaluated naturally in units of A˚3 with MD simulations, can
be converted to the standard state volume by the constant C.
One may note that the effective volume DV is typically on
the order of;1 A˚3. Therefore, for all practical purposes, it is
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always much smaller than the standard state volume of 1661
A˚3, e.g., a DV equal to 1 A˚3 (a typical value) yields the well-
known standard state offset factor kBT ln(C) of 4.4 kcal/
mol. For this reason, the reduction in translational freedom of
the ligand makes an unfavorable contribution to binding free
energy.
Similarly, it is informative to consider the total free energy
contribution associated with the rotation of the ligand DDGr
obtained by combining DGsiter and Fr,
e
bDDGr ¼ ebDGsiter 3Fr
¼
R
site
dðLÞ R dXeb½U11uc1ut R
site
dðLÞ R dXeb½U11uc1ut1ur 3
R
dVLe
burðVLÞR
dVL
¼
R
dVLP
site
r ðVLÞR
dVLP
site
r ðVLÞeburðVLÞ
3
R
dVLe
burðVLÞR
dVL
; (7)
where Psiter is the distribution of the orientation angles
(this Psiter depends on ut). In the limit of strong rotational
restraint potential ur(V), the bias potential acts essentially as
a d-function,
e
burðVLÞR
dVLe
burðVLÞ  dðVL VmÞ; (8)
which is sharply peaked atVm, the maximum of P
site
r , i.e., the
most probable orientation of the ligand in the binding site.
For a nonlinear ligand, it follows that
e
bDDGr  1R
site
dVL
Z
site
dVL
P
site
r ðVLÞ
P
site
r ðVmÞ
¼ DV
8p
2: (9)
It may be noted that the factor DV/8p2 is necessarily
smaller than (or equal to) 1. For this reason, the reduction in
rotational freedom of the ligand always makes an unfavor-
able contribution to binding free energy.
The above analysis shows that reduction in both transla-
tional and orientational freedom yield unfavorable contribu-
tions to the binding free energy. To clarify the signiﬁcance of
this result further, it is useful to relate DV and DV to the
properties of the bound ligand. Assuming that the thermal
ﬂuctuations of the (fully interacting) ligand in the binding
site are Gaussian, DV has the closed-form expressions
DV 
Z
site
drLe
b½ðrLr0Þ2=2s2r 1 ðuLu0Þ2=2s2u1 ðfLf0Þ2=2s2f 
 ð2pÞ3=2r20sinðu0ÞðsrsusfÞ (10)
and DV,
DV 
Z
site
dVLe
b½ðaLa0Þ2=2s2a1 ðbLb0Þ2=2s2b 1 ðgLg0Þ2=2s2g 
 ð2pÞ3=2sinða0ÞðsasbsgÞ; (11)
where s2x ¼ Æðx  ÆxæÞ2æ represent the thermal ﬂuctuations of
each variable. Such Gaussian approximation may be advan-
tageous if one is attempting to estimate the translational and
orientational contributions to the standard binding free
energy using only the information extracted from an unbi-
ased simulation of the fully interacting ligand, i.e., without
actually performing FEP/MD simulations. One may note
also some similarity with the MM-PBSA scheme (68), in
which the translational and orientational contributions are
estimated using a quasi-harmonic approximation (69,70).
Solvation free energy of the ligands
Step 7 provides the solvation free energy of a ligand that is
restrained by uc to remain near its bound conformation. This
does not correspond to the true solvation free energy of a
ﬂexible ligand (e.g., the process ligand in vacuum/ ligand
in solvent). The latter may be expressed as
DGsolv ¼ DGbulkint  DGbulkc 1DGvacc ; (12)
where DGvacc is the free energy corresponding to applying
the conformational restraint on the ligand decoupled from its
surrounding ([ vacuum). The values DGbulkc and DG
bulk
int are
the same as deﬁned above. Therefore, one additional
quantity (DGvacc ) must be computed if one is interested in
evaluating the solvation free energy of the ligand. For the
sake of comparison with the results of Pande, Shirts and co-
workers (63,64), we also computed the solvation free energy
of the ligands, though in practice, this quantity is not required
to compute the standard binding free energy.
Atomic models and computational details
The eight FK506-related ligands (ligands 2, 3, 5, 6, 8, 9, 12,
and 20) are shown in Fig. 1. These ligands are numbered
according to previous experimental (60) and computational
work (63). Ligand 20 is the molecule FK506 (56). Three
types of starting structures were considered for the compu-
tations. The ﬁrst set comprises the crystal structures with
ligands 8, 9, and 20 (PDB code 1FKG, 1FKH, and 1FKJ,
respectively). The second set corresponds to models for
ligands 3 and 5 obtained by construction from the crystal
structure of FKBP12 in complex with ligand 9. Replacing
the cyclohexyl group of ligand 9 with a hydrogen gives
ligand 5, while replacing the phenylmethyl group of ligand
5 with a hydrogen gives ligand 3. Ligands 3 and 5 are highly
similar to ligand 9, and the direct modeling is justiﬁable. The
third set was provided by M. R. Shirts and V. S. Pande
(personal communication, 2005); it corresponds to atomic
coordinates of docking models of ligands 2, 3, 5, 6, and 12
and crystal structures for ligands 8, 9, and 20, followed by
200 ps of MD simulations with explicit solvent. In all the
tables, the three sets are referred to as x-ray, mod, and
MD, respectively. The CHARMM biomolecular simulation
program was used for all the simulations. To compare
with previous calculations by Pande, Shirts and co-workers
(63,64) and J. M. Swanson and J. A. McCammon (personal
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communication, 2005), the same atomic force ﬁeld was used
in this study. The force ﬁeld for the protein is AMBER99,
and that for the ligands is from the 2002 version of general
AMBER force ﬁeld (71) as provided byM. R. Shirts (personal
communication, 2005)). The charges of the ligands are from
AM1/BCC (72). The conversion of the AMBER force ﬁeld
to CHARMM format is given in Appendix B.
The GSBP method (73,74), implemented in the biomo-
lecular simulation program CHARMM (75), was used to
solvate a spherical region centered on the FKBP12 binding
site. In GSBP, the system is divided into an outer and an
inner region. In the inner region, the ligand, the solvent
molecules, and part of the macromolecule are simulated ex-
plicitly with MD. In the outer region, the remaining protein
atoms are included explicitly while the solvent is represented
as a continuum dielectric medium. The inﬂuence of the
surrounding outer region on the atoms of the inner region is
represented in terms of a solvent-shielded static ﬁeld and a
solvent-induced reaction ﬁeld. The reaction ﬁeld due to
changes in charge distribution in the dynamic inner region
is expressed in terms of a basis set expansion of the inner
simulation region charge density. The basis set coefﬁcients
correspond to generalized electrostatic multipoles. The
solvent-shielded static ﬁeld from outer macromolecular atoms
and the reaction ﬁeld matrix, representing the couplings
between the generalized multipoles, are both invariant with
respect to the conﬁguration of the explicit atoms in the inner
simulation region. They are calculated only once for mac-
romolecules of arbitrary geometry using the ﬁnite-difference
PB equation, leading to an accurate and computationally
efﬁcient hybrid MD/continuum method for simulating a
small region of a large biological macromolecular system. A
spherical inner region of 15 A˚ radius was used for all the
ligands. The size of the GSBP simulated systems is typically
;2500 atoms. The systems were hydrated with a ﬁxed
number of water molecules, though this could be generated
dynamically using grand canonical Monte Carlo (76).
Dielectric constants of 80 and 4 were assumed for the sol-
vent and the protein in the outer region, respectively. The
static ﬁeld arising from the protein charges in the outer
region and the generalized reaction ﬁeld matrix including
ﬁve electric multipoles were calculated using the PBEQ
module (77,78) of CHARMM (75) and stored for efﬁcient
simulations. A spherical restraining potential was applied to
keep the water molecules from escaping the inner region
using the MMFP GEO command. The spherical GSBP
simulation system is illustrated in Fig. 2 in the case of ligand
8. During the simulation, protein atoms near the edge of the
boundary are ﬁxed while a nonpolar potential keeps the
water molecules inside the sphere. Each system of ligand/
FKBP12 solvated with GSBP was equilibrated for 2 ns at
300 K using Langevin dynamics. A friction coefﬁcient of
5 ps1 was assigned to all nonhydrogen atoms. A time-step
of 2 fs was used. The average structure of the ligand was
calculated from the equilibration trajectory (typically from
0.4 ns to 2 ns), which was then used as a reference structure
Lref in the conformational restraining potential uc. The
ﬂuctuations of the six internal variables (rL, uL, fL, aL, bL,
and gL) used in the translational and rotational restraining
potentials were monitored to estimate the force constants for
the biasing restraining potentials.
Protocol for binding free energy (steps 1–8)
Conformational restraints (steps 1 and 8)
For better accuracy, the free energies associated with the
conformational restriction of the ligand near the reference
conformation, DGsitec and DG
bulk
c (Steps 1 and 8), was not
obtained directly by FEP/MD simulations, but was calcu-
lated by integration of the Boltzmann factor of the RMSD
potential of mean force (PMF) obtained from umbrella
FIGURE 1 Structural formulae of the eight ligands used in the calcula-
tion. Ligands 2, 5, 6, 8, and 9 have one or two physically symmetric units
(phenyl or cyclohexyl group). Flat-bottom dihedral restraints were applied
on these symmetric units to prevent exchange between physically equivalent
conformers. Ligand 20 is also referred to as FK506 in the literature (60). The
atoms labeled in red and blue are the atom used to deﬁne the point-positions
L1 and L2, respectively in Fig. 3.
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sampling simulations. For the ligand in the bulk, DGbulkc is
given by
e
bDGbulkc ¼
R
dze
b½wbulkc ðzÞ1kcz2 R
dze
bwbulkc ðzÞ
; (13)
where wbulkc ðzÞ is the ligand PMF as a function of the RMSD
relative to Lref in bulk solution. Similar expressions hold for
DGsitec and DG
vac
c . The umbrella sampling method (79) was
used to evaluate the PMF as a function of RMSD. To insure
a uniform sampling of the RMSD, the simulations were
generated using a quadratic biasing potential of the form
kc(z[L;Lref]  zi)2 centered on successive values of zi.
Speciﬁcally, 21 biasing windows were used with the RMSD
offset value increasing from 0.0 to 4.0 A˚ in steps of 0.2 A˚ for
the ligand in the binding site, and 21 windows were used
with the RMSD offset value increasing from 0.0 to 5.0 A˚ in
steps of 0.25 A˚ for the ligand in the bulk solution. The initial
conﬁgurations for the 21 umbrella sampling windows were
generated using a short initial run with a strong force con-
stant kc (500 kcal/mol/A˚
2). Then, each window was equil-
ibrated using a force constant of 10 kcal/mol/A˚2, and after
sufﬁcient equilibration; a 1-ns simulation was used for sam-
pling. No translational or orientational restraining potential
is present during those simulations. The weighted histogram
analysis method (80–82) was used to unbias the results and
compute the PMF as a function of RMSD. An optimal force
constant for the conformational restraining potential uc ¼
kcz
2 was determined from the RMSD-PMF of the ligands
in solution and in the binding site. Speciﬁcally, a value of
10 kcal/mol/A˚2 was chosen for kc so that the normalized
Boltzmann probability of the conformationally restrained
ligand in the bulk or bound to the protein both have their
most probable values around the same small RMSD (;0.5–
1.0 A˚).
Some ligands have symmetric structural elements (e.g.,
the two phenyl groups of ligand 8 as shown in Fig. 1), which
can undergo isomerization and exchange between physically
equivalent conformations. Sampling all these (physically
indistinguishable) conformations may become prohibitively
slow when the ligand is in the binding site, but less so in the
solvent. With ﬁnite-length trajectories, isomerizations could
take place frequently during the FEP/MD simulation of the
ligand in solvent, but not in those of the bound complex. A
proper accounting of the relative conformational entropy
cost upon ligand binding will be compromised by such
nonequivalence in sampling one state of the system, but
not the other. This problem can be avoided by limiting the
conformational space to a single one of the physically equiv-
alent rotamers of the ligand in all the FEP/MD simulations.
In the present calculations, a steep ﬂat-bottom dihedral
restraining potential was applied to all the symmetric units of
the ligand to prevent exchange between identical rotameric
states during the simulations. It should be noted that such
ﬂat-bottom restraining potential does not affect the physical
properties of the ligand and the ﬁnal binding free energy as
long as it is present during all the computations, with the
ligand in the solvent and in the binding site. The restriction
was applied to the ligand during all the free energy cal-
culations involving the conformational restraining potential
uc (the ligand in the binding site, in solution, and in vacuum
for the solvation free energy calculations). The force con-
stant for the ﬂat-bottom restraint is 500 kcal/mol/rad2.
Translational and rotational restraints (Steps 2 and 3)
The free energies corresponding to the translational and
rotational restraints with the ligand in the binding site, DGsitet
and DGsiter , were calculated using FEP/MD simulations. The
translational (ut) and rotational (ur) restraints were gradually
turned on via the linear coupling parameters kt and kr (with
values of 0.0, 0.025, 0.05, 0.075, 0.1, 0.2, 0.4, 0.6, 0.8, and
1.0). The six point-positions in the protein (Pc, P1, and P2)
and the ligand (Lc, L1, and L2) used to deﬁne the relative
position and orientation of the ligand with respect to the
protein are illustrated in Fig. 3 in the case of ligand 8.
Interaction energy (Steps 4 and 7)
The contribution corresponding to the interaction energy of
the ligand with its surrounding, DGsiteint and DG
bulk
int , were
calculated with FEP/MD simulations. For this purpose, the
Lennard-Jones (LJ) potential was separated into repulsive
FIGURE 2 A sphere containing FKBP12, ligand 8, and water molecules
in the GSBP method. The crystal structure (pdb code: 1FKG) of the complex
of FKBP12 (green, cartoon) and ligand 8 (red, ball-and-stick) is solvated in
water molecules (blue, small spheres). In the GSBP method, only atoms in a
sphere (15 A˚ radius) centered on the ligand are represented explicitly. All
atoms outside the sphere were removed and were represented implicitly
using the continuum method. The dielectric constants of the solvent and the
protein in the outer region are 80 and 4, respectively.
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and dispersive free energy using the Weeks Chandler
Andersen (WCA) method (51,83). A nonlinear coupling
parameter s was introduced to control the repulsive part, and
a linear coupling parameter j was introduced to control the
dispersive part. Furthermore, a linear coupling parameter l
was introduced to control the electrostatic interactions. Such
separation of the potential with these coupling parameters
permits an accurate evaluation of the free energy and a clear
step-by-step decomposition of the nonbond interactions into
repulsive, dispersive, and electrostatic contributions (52).
Though the free energy decomposition of the nonbonded
interactions formally depends on the order in which each of
these contributions are activated, introducing the repulsive
core in the ﬁrst step is an unavoidable physical necessity. A
molecular entity with dispersive attraction and charges, but
no core repulsion, makes no physical sense (the energy does
not have a lower bound). The dispersion and electrostatics
could be interchangeably introduced as in second or third
steps, with little impact on the free energy decomposition,
because those do not greatly affect the structure of the
solvent. Therefore, the resulting free energy decomposition
can lead to useful observations because the step-by-step
FEP/MD procedure goes through physically meaningful
intermediates. In the context of a particle insertion process,
the repulsive interaction is ﬁrst introduced gradually (s ¼ 0,
0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, and 1), while the
dispersive and electrostatic interactions are turned off (j ¼ 0
and l ¼ 0). Then, in the presence of the repulsive interac-
tion (s ¼ 1), the dispersive interaction is turned on gradually
(j ¼ 0.0, 0.25, 0.5, 0.75, and 1.0) while the electrostatic
interaction is turned off (l ¼ 0). Finally, the electrostatic
interaction are gradually turned on (l ¼ 0.0, 0.1, 0.2, 0.3,
0.4, 0.5, 0.6, 0.7, 0.8, 0.9, and 1.0) in the presence of both the
repulsive and dispersive interactions. For each set of
coupling parameters, 120-ps Langevin dynamics was gen-
erated and averages were calculated using the last 100 ps
(additional simulations of 1 ns were generated to check the
convergence). The results were unbiased using the weighted
histogram-analysis method facility of CHARMM. The free
energy components (repulsive, dispersive, and electrostatic
free energies) were calculated for the ligand in the binding
site or in the bulk solution. For the GSBP simulations, the
atoms of the protein in the outer region are not kept explicitly
for the sake of computational efﬁciency. All the FEP window
simulations were generated concurrently starting from the
structure of the equilibrated system. The contribution from
the long-range van der Waals dispersive interaction with the
(missing) atoms of the outer region (solvent and protein) was
evaluated from a snapshot of a large all-atom model of the
solvated protein with its ligand, and was included in the
free energy. The large system was built with 8000 water
molecules (length; 60 A˚) and the full protein for the ligand
in the binding site. For the ligand in the bulk solution,
1000 water molecules (length of ;30 A˚) were used. The
difference between the bulk and the binding site nearly
cancel out, with the magnitude of each component being on
the order of 1.0 kcal/mol. For example, the long-range
corrections of ligand 8 in the binding site and in the bulk are
0.9 and 1.5 kcal/mol, respectively. Though the magni-
tude of the long-range correction depends on the cutoff used
for the nonbonded interactions, its net impact on the total
binding free energy is similar to the values of Pande, Shirts
and co-workers (63,64) for similar cutoff (see Table 5.2 in (64)).
All the results are given in Table 1.
Translational and orientational factors (Steps 5 and 6)
The translational factor Ft was calculated numerically from
the expression
Ft ¼
Z N
0
drLr
2
L
Z p
0
duLsinðuLÞ
Z p
p
dfLe
butðrL ;uL ;fLÞ; (14)
where ut ¼ 1/2[kt(rL  r0)2 1 ka(uL  u0)2 1 ka(fL  f0)2]
is a quadratic translational restraining potential. The value kt
is the force constant for the distance restraint, and ka is the
force constant for the angle and dihedral restraints; r0, u0, and
f0 are the reference values of the distance, angle, and
dihedral determined from an average of the equilibration
trajectory and subsequently used to deﬁne the position of the
ligand.
Similarly, the orientational factor Fr was calculated
numerically from the expression
FIGURE 3 Translational and rotational restraints on ligand 8. Three
random point-positions in the protein (Pc, P1, P2) and three random point-
positions in the ligand (Lc, L1, and L2) were chosen to set up the translational
and rotational restraints. They are the center-of-mass of the protein (green)
in the sphere, residue Val-101, residue Tyr-26, the ligand (red), atoms
labeled in red in Fig. 1, and atoms labeled in blue in Fig. 1, respectively.
These positions are shown in yellow spheres with dashed blue lines con-
necting them. The translational restraint is deﬁned by r (PcLc), u (P2PcLc),
and f (P1P2PcLc). The rotational restraint is deﬁned by a (PcLcL1), b
(P2PcLcL1), and g (PcLcL1L2).
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Fr ¼ 1
8p
2
Z p
0
daLsinðaLÞ
Z p
p
dbL
Z p
p
dgLe
burðaL ;bL ;gLÞ;
(15)
where ur¼ 1/2[ka(aL  a0)21 ka(bL  b0)21 ka(gL  g0)2]
is a quadratic orientational restraining potential. The value ka
is the force constant for the angle and dihedral restraints; a0,
b0, and g0 are the reference values of the angle and dihedrals
determined from an average of the equilibration trajectory
and subsequently used to deﬁne the orientation of the ligand.
RESULTS AND DISCUSSION
The calculated standard binding free energy with the various
components are given in Table 2 for the eight FK506-related
ligands shown in Fig. 1. In the following, the various steps of
the FEP/MDmethodology for computing the standard binding
free energy are illustrated in the case of ligand 8. Then, general
observations are made about the results for the eight ligands.
Illustrating the FEP/MD method with ligand 8
The reduced FKBP12/ligandGSBP system is shown in Fig. 2.
Only the atoms in the inner region (deﬁned as a sphere of 15 A˚
radius) are simulated explicitly. The inner region includes the
ligand (red, ball-and-stick), the water molecules (blue, small
spheres), and a part of the protein (green, cartoon). The
inﬂuence of the remaining atoms in the outer region (protein
and solvent) is included implicitly. The static and reaction
ﬁeld arising from the protein and solvent in the outer region is
evaluated using a continuum electrostatic approximation. The
static ﬁeld represents the electrostatic inﬂuence from the
protein charges in the outer region, shielded by the complex
geometry of the protein-solvent interface. The reaction ﬁeld
represents the polarization of the dielectric solvent in the outer
region in response to the explicit charges in the inner region.
First, the FKBP12/ligand GSBP system was equilibrated
(for 2 ns) with Langevin dynamics without any biasing
restraint. The ﬁnal snapshot of the equilibration (rather than
some average) was used as the input structure for FEP/MD
simulations. Fig. 4 A shows the RMSD ﬂuctuations of the
nonhydrogen atoms of the protein (black), ligand (red), and
the ﬂuctuation of the center-of-mass of the ligand (green).
The simulated system appears to be very stable. Fig. 4 B
shows the ﬂuctuation of the six relative coordinates (rL, uL,
fL, aL, bL, and gL), which are used subsequently to imple-
ment translational and rotational restraining potential. Those
internal coordinates are deﬁned from six point-positions con-
structed from the Cartesian coordinates of the protein-ligand
complex (see Fig. 3). The RMS ﬂuctuation in the distance rL
(black) is ;0.5 A˚, while those of the angles are ;10. As
shown previously, an optimal value of the force constant for a
restraining potential is to choose kx  kBT/ÆDx2æ (53). Thus,
for the FEP/MD simulations, the force constants for the
distance restraint and the angle/dihedral restraint were chosen
as 1 kcal/mol/A˚2 and 200 kcal/mol/rad2, respectively.
Nonbond interaction free energy
The nonbond free energy calculation bears the major part of
the computational cost to calculate the standard binding free
energy. The conformational, translational, and orientational
restraining potentials are applied on the ligand during the
FEP/MD simulations (Steps 4 and 7). (The translational and
orientational potentials have no inﬂuence on the FEP/MD
simulations of the ligand in the isotropic bulk.) As a result, the
TABLE 1 Nonbond free energy components for the binding
of ligands to FKBP12
Lig Struct DGsiterep DG
site
dis DG
site
elec DG
bulk
rep DG
bulk
dis DG
buk
elec
2 MD 30.8 47.3 17.5 30.5 28.8 13.6
3 mod 34.9 47.7 18.1 29.5 26.2 13.5
3 MD 35.7 45.5 23.8 25.4 21.3 19.8
5 mod 35.9 51.3 21.2 30.6 27.3 15.2
5 MD 36.4 53.1 21.0 34.5 32.1 16.3
6 MD 40.4 57.4 25.9 38.9 38.2 19.6
8 X ray 41.2 62.3 22.1 42.3 41.2 18.4
8 MD 45.4 63.1 22.2 44.4 42.0 18.8
9 X ray 44.5 61.6 21.4 45.3 43.2 15.9
9 MD 51.0 66.0 21.0 45.1 42.3 15.9
12 MD 41.6 58.1 28.8 34.2 31.4 24.6
20 X ray 58.8 84.4 31.1 59.4 61.9 32.5
20 MD 56.5 84.0 30.9 57.0 60.2 32.2
Three sets of structures were used. X-ray means x-ray crystal structure; mod
means the structure is modiﬁed from the crystal structure of ligand 9 by
replacing some groups with hydrogen. MD means the structure is modeled
from crystal structures and equilibrated for ;200 ps by Shirts (64). The
nonbond free energy components include repulsive (DGrep), dispersive
(DGdis), and electrostatic (DGelec) free energy. The long-range van der
Waals correction is included in DGdis. The superscripts site and bulk
indicate the ligand is in the binding site or in the bulk solution, respectively.
TABLE 2 Free energy components for the binding of
ligands to FKBP12
Lig Struct 1DGsiteint DGbulkint 1 DDGc 1 DDGt 1 DDGr DGbind
2 MD 34.0 11.8 2.2 3.2 4.4 12.3
3 mod 30.9 10.2 3.1 3.7 5.2 8.7
3 MD 33.6 15.7 2.0 3.3 3.5 9.0
5 mod 36.7 12.0 5.5 3.5 5.4 10.2
5 MD 37.8 13.9 3.5 3.5 5.2 11.6
6 MD 42.9 19.0 5.5 3.3 5.4 9.7
8 X ray 43.3 17.2 6.9 3.4 5.4 10.3
8 MD 39.9 16.3 5.6 3.3 4.2 10.3
9 X ray 38.6 13.8 4.5 3.5 5.0 11.7
9 MD 35.9 13.0 3.4 3.4 4.6 11.6
12 MD 45.2 21.8 1.0 3.4 5.3 13.7
20 X ray 56.7 34.9 2.7 3.3 5.6 10.1
20 MD 58.4 35.5 3.3 3.4 5.4 10.8
Note each free energy component was corrected with the sign already. The
ligands are labeled as in Table 1. The value DGsiteint and DG
site
int are the total
nonbond free energies, which are equal to the sum of nonbond free energy
components in Table 1. The values DDGc, DDGt, and DDGr are the net
free energies corresponding to the conformational restraints, the transla-
tional restraint, and the rotational restraint, respectively (Eq. 3). The value
DGbind is the standard binding free energy.
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uncoupled ligand retains its bound conformation (on aver-
age), and remains in place even after its interactions with the
protein and the solvent are turned off. This is clearly
advantageous because a ﬂoppy and uncoupled ligand wan-
dering freely in the simulation system dramatically increases
the size of the conﬁgurational space that needs to be explored
during the FEP/MD simulations, which can give rise to sig-
niﬁcant sampling problems. A faster convergence can be
achieved using restraining potentials (see also the discussion
in Boresch et al. (21) andWoo and Roux (22)). However, one
should keep inmind that the speciﬁc values for the nonbonded
contribution depend on the applied translational, orientational
and conformational restraints; variations on the order of 1.0
kcal/mol between different runs with slightly different refer-
ence values for the restraints are common.
To further improve the convergence, the LJ interaction is
separated into dispersive and repulsive free energy using the
WCA decomposition (51). This separation of the LJ poten-
tial into pure repulsive and dispersive parts is somewhat arbi-
trary (others would be possible), though it has the advantage
of clearly identifying positive- and negative-deﬁnite contri-
butions to the free energy, respectively. The nonbond free
energy components (dispersive, repulsive, and electrostatic
free energies) are calculated with FEP/MD simulations by
gradually varying the coupling parameters j, s, and l, re-
spectively (see Methods). Fig. 6, A–C, shows the nonbond
free energy components as a function of the corresponding
coupling parameters for ligand 8 in the binding site (solid
square) and in the bulk solution (dashed triangle), respec-
tively. The repulsive free energy (Fig. 6 A) both in the binding
site (solid) and in the bulk solution (dashed) is;40 kcal/mol.
Thus, the repulsive part of the LJ potential makes only a
small net contribution to the binding free energy. In contrast,
the dispersive free energy (Fig. 6 B) in the binding site (solid)
is much larger than that in the bulk solution (dashed). The
difference is ;20 kcal/mol, strongly favoring ligand bind-
ing. The electrostatic free energy (Fig. 6 C) in the binding site
(solid) is ;4 kcal/mol more negative than that in the bulk
solution (dashed), and thus contributes favorably to binding.
Therefore, the dispersive van der Waals attraction strongly
favors binding. In other words, an isosteric nonpolar analog
to ligand 8 would still bind to FKBP, even without any
electrostatic contributions from ligand partial-charges. This is
a general observation for all the ligands considered here
(see below).
RMSD potential of mean force
A key feature of the present strategy is the RMSD restraining
potential uc, designed to keep the ligand near the bound
conformation. Such restraining potential is an effective
device to control the global conformation of a molecule
(84,85). Though usefulness of such RMSD restraint becomes
more limited in the case of very large structures, drug-like
ligands are generally small molecules and their conformation
can be accurately controlled without problem. To clarify the
signiﬁcance of the contribution from the RMSD restraining
potential, we examine the PMF of the ligand as a function of
the RMSD relative to its conformation when bound to the
protein. Fig. 5 A shows the PMF as a function of the RMSD
values calculated for ligand 8 in the binding site, in the bulk
FIGURE 4 Equilibration of the GSBP system containing ligand 8 in
complex with FKBP12. (A) RMSDs of the heavy atoms in the protein
(black) and in the ligand (red), and the ﬂuctuation of the center-of-mass of
the ligand (green). (B) The ﬂuctuation of the six parameters used to deﬁne
the translational and rotational restraints. The curves are labeled with r
(black), u (red), f (green), a (blue), b (yellow), and g (brown), respectively.
(C) The ﬂuctuation of the two dihedrals next to the two symmetric phenyl
groups shown in Fig. 1. The ﬂuctuation of f1 is shown in black and the
ﬂuctuation of f2 is shown in red.
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solution, and in vacuum using umbrella sampling simulations.
The PMF for the binding site (black) has an absolute
minimum at ;0.4 A˚, with a secondary minimum at ;2 A˚.
The PMF shows that in the binding site, ligand 8 is stable
around its average bound structure calculated from the equili-
bration trajectory. It also indicates that ligand 8 can adopt a
different conformation, which is slightly less favorable by
;1.3 kcal/mol, while it remains bound to FKBP12. The
main (i) and secondary (ii) ligand conﬁgurations, illustrated
in Fig. 5 B, differ mostly by the rotation of one aromatic ring
that interacts weakly with the protein. The PMF in the bulk
solution (green) shows a broad minimum at;2 A˚. The most
stable conformation of ligand 8 in the solvent (iii), illustrated
in Fig. 5 B, differs mostly by the rotation of two of the
aromatic rings. The PMF shows that any conformations
differing from the bound state by 1.5 to 3.5 A˚ RMSD should
be accessible through thermal ﬂuctuations. Obviously, there
is a free energy penalty to bring the conformation of the
ligand, moving freely in the bulk solution, to the conforma-
tion it must adopt in the binding site. The free energy required
to restrict the conformation of the ligand is determined
numerically using Eq. 13. The value of 6.9 kcal/mol given in
Table 2 can be easily understood from a direct comparison of
the two PMFs in Fig. 5 A. The PMF of the ligand in the sol-
vent (green) goes up to 7 kcal/mol at an RMSD cor-
responding to the minimum of the PMF in the binding site
(black, ;0.4 A˚). In other words, ;7 kcal/mol of conforma-
tional free energy is required to transform the ligand from its
most probable conformation in the bulk (iii), to its most prob-
able conformation in the binding site (i). The PMF in vacuum
(red) has many similarities with the PMF in the bulk solution,
though the minimum at 2.5 A˚ is not as broad.
The optimal force constant kc to restrict the ligand around
its average bound conformation was determined from the
calculated PMF. Fig. 5 C shows the normalized (biased)
Boltzmann distribution exp ½b½wsitec ðzÞ1kcz2, exp ½b
½wbulkc ðzÞ1kcz2, and exp ½b½wvacc ðzÞ1kcz2 as a function
of the RMSD z for the ligand in the binding site (black), in
the bulk solution (green), and in vacuum (red), respectively.
With a force constant of 10 kcal/mol/A˚2, the conformational
distribution functions of the ligand in all the systems (bind-
ing site, bulk solution, and vacuum) have a high overlap at
;0.5 A˚ RMSD. Such force constant insures that the ligand is
kept near the reference conformation Lref during the
calculations for Steps 2, 3, 4 and 7.
Using restraints of different strength
The present computational strategy attempts to enhance the
conﬁgurational sampling of the molecular systems using
biasing restraints. Optimal values for the calculations use a
force constant kc for the conformational restriction of
10 kcal/mol/A˚2, a distance force constant kt of 1 kcal/mol/A˚
2,
and an angle/dihedral force constant ka of 200 kcal/mol/rad
2.
Fig. 6 D shows the progression of the free energies corre-
FIGURE 5 PMF calculations on the conformational restraints for ligand
8 in complex with FKBP12. (A) PMF curves for ligand 8 in the binding site
(black), in the bulk solution (green), and in vacuum (red). The callouts i and
ii label the minima of the PMF for the ligand in the binding site. The callouts
iii and iv label the minima of the PMFs for the ligand in the bulk solution and
in vacuum, respectively. (B) The average structures of the ligand around the
minima are shown together with the average structure of the ligand in the
equilibration (shown in yellow). The average structures of the ligand around
the minima i, ii, iii, and iv are colored in black, gray, green, and red, re-
spectively. The structures are aligned along the piperidine ring in ligand 8.
(C) The normalized Boltzmann factors exp[b(wc(j) 1 kcj2)] with a force
constant kc ¼ 10 kcal/mol/A˚2 for the ligand in the binding site (black), in the
bulk solution (green), and in vacuum (red).
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sponding to the translational (circles) and rotational (diamonds)
restraints applied to the ligand in the binding site. The
resulting values are typically on the order of 1–2 kcal/mol,
and the FEP/MD simulations converge without problems.
However, a legitimate concern might be that the ﬁnal results
for the binding free energy remain tainted by the choice of
force constants for the restraints.
To address this issue, the absolute binding free energy was
recalculated for ligand 8 using different force constants kc, kt,
and ka. The results are given in Table 4. It is observed that the
ﬁnal binding free energy is nearly independent of the biasing
restraints, even when the force constants are varied by a large
amount. All the calculations in Table 3 used the same set of
force constants, with kc ¼ 10 kcal/mol/A˚2, kt ¼ 1 kcal/mol/
A˚2, and ka ¼ 200 kcal/mol/rad2. When the force constants kt
and ka are varied, only the following free energy components
change: the net free energy contribution associated with the
translational and rotational freedom (DDGt andDDGr), and the
nonbond interaction free energy contribution of the ligand in
the binding site (DGsiteint ). In the case of the conformational
restraint, it may be noted that the accuracy appears to be
somewhat compromised if the force constant is,;1.0 kcal/
mol/A˚2. The main reason is that the uncoupled ligand in the
binding site begins to adopt conformations different from the
average bound conformation, which makes the calculation
slower to converge. It is therefore advantageous to use re-
straints that are sufﬁciently strong to avoid this problem.
Standard binding free energies
In Table 3, the results of the calculations for the eight ligands
are comparedwith the experimental values (60), and the results
from extensive FEP/MD calculations by Pande, Shirts and co-
workers (64). The results are in good agreement with the
experimental results, especially in the case of ligands forwhich
it is possible to have a good starting structure of the complex
either from x-ray crystallography (ligands 8, 9, and 20) or by
simple direct modeling (ligands 3 and 5). The differences are
within 1 kcal/mol for most ligands, which is roughly the order
of magnitude of the statistical errors of calculations. The
calculated binding free energies for a given ligand obtained
from different starting structures, e.g., ligand-8 x-ray and MD
(64), are very similar, though the errors appear to be smaller for
crystal structures in general. The solvation free energy of the
ligands offers one additional (simpler) quantity to directly
assess the accuracy of the present computations by comparing
with the previous results of V. S. Pande and co-workers
(personal communication, 2005). As shown in Table 3, the
solvation free energies calculated according to Eq. 12 are very
consistent with those results, except for ligands 3 and 5.
Overall, we conclude that the present strategy, based on FEP/
MD simulations of a reduced GSBP atomic model sampled
with conformational, translational, and orientational restrain-
ing potentials, is accurate and efﬁcient.
Nonbond contribution
Table 1 shows the nonbond free energy components (disper-
sive, repulsive, and electrostatic free energy) for all ligands in
the binding site and in the bulk solution. The nonbond free
energy of the ligand in the binding siteDGsiteint is typically;20
kcal/mol more negative than that of the ligand in the bulk
solutionDGbulkint . Generally,DG
site
int andDG
bulk
int increasewith the
size of the ligand (in the order 2, 3, 5, 6, 8, 9, 12, and 20). As
FIGURE 6 The free energy compo-
nents are gradually turned on as the
parameters increase from 0 to 1 for ligand
8 in complex with FKBP12. The nonbond
free energy components (A–C) for the
ligand in the binding site (solid line,
square) and the ligand in the bulk solution
(dashed line, triangle) are shown as solid
and dashed lines, respectively. (A) Repul-
sive free energy. (B) Dispersive free
energy. (C) Electrostatic free energy. (D)
The free energies corresponding to the
translational (shown with circle symbols
and kt) and rotational (shown with ¤ and
kr) restraints applied to the ligand in the
binding site.
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expected for nonpolar ligands, there is only a minor contri-
bution from the electrostatic free energy. The net contribution
from the repulsive free energy appears to be generally small for
most ligands. The reason for this may be that the binding
pocket is at the surface of FKBP12 and that the bound ligand
remains solvent-exposed. The trend was somewhat different
for the binding of aromatic ligands to amutant of T4 lysozyme
engineered to have a buried nonpolar cavity. In that case, the
calculated contribution from the repulsive interaction was
more important (52). For the FK506-related ligands, the
dispersive interactions make the dominant contribution to the
binding free energy (;20–30 kcal/mol).
The importance of dispersive interactions in driving the
binding process can be understood from the relative density
of the bulk relative to the protein. There is a larger number of
atomic (nonhydrogen) van der Waals interaction centers per
unit volume in the protein compared with liquid water. The
transfer of a nonpolar ligand from the bulk to the binding
site almost invariably yields a change of van der Waals
dispersive interactions that favors association. Obviously,
the favorable van der Waals interactions increase with the
size of the ligand in general. These observations suggest that,
to describe ligand binding with quantitative accuracy, one
needs to account for the variations in the repulsive and
attractive free energy contributions in the different environ-
ment of the bulk or the binding site. A similar observation
has been made by Levy et al. (86).
Loss of conformational, translational, and
orientational freedom
The net contribution from the translational free energy DDGt
is ;3 kcal/mol, though it goes up to 4.5 kcal/mol in the case
of ligand 8 with a stronger restraint (Table 4). Since DDGt
kBT ln(DVC), this would indicate that the center-of-mass
of the bound ligand is ﬂuctuating inside a microscopic
volume DV on the order of ;1 A˚3. For example, DDGt is
estimated to be 4.6 kcal/mol using the ﬂuctuations of the
bound ligand in unbiased simulations in Eq. 10 in the case of
ligand 8. Similarly, the loss of orientational freedom gives
rise to a signiﬁcantly unfavorable contribution. The net con-
tribution from the rotationalDDGr is;5 kcal/mol, which cor-
responds to a signiﬁcant reduction of orientational freedom
(accessible solid angle of rotation) DV from 8p2. This was
also previously noted by Swanson and McCammon (70). In
the case of ligand 8 again, DDGr is estimated to be 5.0 kcal/
TABLE 3 Binding free energy and solvation energy compared with other results
DGbind DGsolv
Lig Struct This work Experiments Shirts (64) This work Shirts (64)
2 MD 12.3 6 1.4 7.8 6 0.1 5.42 11.4 6 1.1 13.56
3 mod 8.7 6 0.7 8.4 6 0.1 NA 9.7 6 0.5 NA
3 MD 9.0 6 1.1 8.4 6 0.1 8.22 13.8 6 0.7 16.98
5 mod 10.2 6 1.1 9.5 6 0.1 NA 12.9 6 0.1 NA
5 MD 11.6 6 2.1 9.5 6 0.1 6.92 12.7 6 0.5 15.02
6 MD 9.7 6 2.8 10.8 6 0.3 8.29 18.2 6 1.7 17.36
8 X ray 10.3 6 0.4 10.9 6 0.1 NA 17.3 6 0.9 NA
8 MD 10.3 6 1.2 10.9 6 0.1 10.42 15.4 6 1.9 15.21
9 X ray 11.7 6 1.0 11.1 6 0.2 NA 12.6 6 0.8 NA
9 MD 11.6 6 0.1 11.1 6 0.2 9.11 11.8 6 0.8 13.95
12 MD 13.7 6 2.8 10.3 6 0.2 7.51 22.1 6 2.9 23.49
20 X ray 10.1 6 1.2 12.7 6 0.2 NA 35.1 6 0.7 NA
20 MD 10.8 6 3.0 12.7 6 0.2 13.34 36.4 6 1.4 35.15
The calculated binding free energies are compared with the experimental results (60) and the previous calculations by Shirts (64). The force constants
used are: kc ¼ 10 kcal/mol/A˚2, kt ¼ 1 kcal/mol/A˚2, and ka ¼ 200 kcal/mol/rad2. The error bars in the calculations are the standard deviations of three or more
independent runs. The solvation free energies by M. R. Shirts and co-workers are from personal communication (2005) . NA means data are not available.
TABLE 4 Binding free energy of the FKBP12/ligand 8 complex (started from the x-ray structure) at different force constants for
the RMSD potentials, the translational restraint, and the rotational restraint
kc kt ka 1DG
site
int DGbulkint 1 DDGc 1 DDGt 1 DDGr DGbind
1 1 200 38.6 16.0 2.5 3.4 5.1 11.6
10 1 200 43.3 17.2 6.9 3.4 5.4 10.3
10 0.2 40 42.1 17.2 6.9 2.4 4.4 11.1
10 10 1000 44.4 17.2 6.9 4.5 5.5 10.2
10 100 4000 44.8 17.2 6.9 5.0 5.8 9.8
30 1 200 44.5 17.2 7.6 3.5 5.4 10.8
100 1 200 47.5 19.3 8.5 3.5 5.6 10.6
The value kc (in kcal/mol/A˚
2) is the force constant for the RMSD potentials. The value kt (in kcal/mol/A˚
2) is the distance force constant for the translational
restraint. The value ka (in kcal/mol/rad
2) is the angle/dihedral force constant for the translational and rotational restraints.
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mol using the ﬂuctuations of the bound ligand in unbiased
simulations inEq. 11. Perhapsmore surprising is themagnitude
of the net contribution corresponding to the conformational
restriction of the ligand upon binding, DDGc, which varies
from 2 up to 6–7 kcal/mol depending on the ligand (Table 2).
This is a very signiﬁcant fraction of the standard binding free
energy for those ligands.
Themagnitude of the free energy contributions causedby the
loss of conformational, translational, and orientational freedom
hasconsequences forempirical implicit solvent scoringschemes
attempting to estimate the ligand-protein binding free energy
on the basis of ﬁxed ligand-protein conﬁgurations. For ex-
ample, MM/PBSA consists in averaging the results of PB
calculations based on an ensemble of ﬁxed snapshots generated
by MD simulations with explicit solvent (66). What can be
effectively generated by this procedure is an approximation to
DDGint, the ligand-protein interaction free energy.This contri-
butionmost obviously favors binding.However, the remaining
contributions, which are necessarily unfavorable to binding,
must also be taken into account. To some extent, this may be
achievedwith theuseofapproximateexpressions.Forexample,
reliable estimates of the free energy contributions arising from
the loss of translational and orientational degrees of freedom of
the ligandmay be obtained on the basis of ﬂuctuation averages
using Eqs. 10 and 11.Upon inspection, it seems likely that such
approximation may be valid only for a fairly rigid ligand, or if
a strong conformational restraining potential is applied to a
ﬂexible ligand.However, there is no straightforward estimator
of DDGc. In the case of ligand 8, for example, the free energy
required to conform the ﬂexible ligand in the bulk to its bound
state in FKBP12 (;7 kcal/mol) is not correlated with the
potential energy of the ligand molecule corresponding to
the bound (83.27 kcal/mol) and free (84.73 kcal/mol) con-
formations (both relaxed with energy minimization). Design-
ing an approximation toDDGc is very challenging because it is
essentially dominated by a loss of conformational freedom of
the ligand and not by a change of internal potential energy.
Accuracy and sensitivity to starting structure
Three sets of starting structures were used for the calculations.
A ﬁrst set of structures are x-ray crystallographic structures of
FKBP12 with ligands 8, 9, and 20. A second set of structures
are FKBP12 in complex with ligands 3 and 5, which were
constructed from the crystal structure of ligand 9 (see
Methods). A third set of structures are FKBP12 with all eight
ligands provided by V. S. Pande and co-workers (personal
communication, 2005); these docking models were equili-
brated using MD for ;200 ps with explicit solvent. For each
ligand, the complete FEP/MD calculation was repeated at least
three times (some up to ﬁve) starting from the beginning of the
equilibration. The statistical precision of the calculated free
energy is on the order of;1.0 kcal/mol, though the accuracy of
the calculated value differs depending on the starting structure.
The results summarized in Table 3 highlight the importance of
the starting structure. For example, the results for ligand 8 are
different if initiated from the crystallographic x-ray structure or
from the MD equilibrated system of Pande, Shirts and co-
workers (63,64). In contrast, ligand 5 appears to be particularly
problematic. The ligand-protein complex was somewhat
unstable during the equilibration, giving rise tomore signiﬁcant
variations in the resulting binding free energy.
The present strategy based on biased sampling with
restraining potentials does not require very long simulations
as longas the starting structure is accurate and can remain stable
in this neighborhood (within ;1 A˚). Bad or unstable initial
structures start to drift during equilibration, which makes it
difﬁcult to design an optimal set of restraining potentials aimed
at helping the sampling. In the familiar language of compu-
tational drug design, one might say that the present strategy is
well suited to assign a value to a given ligand conﬁguration
(deﬁned within ;1 A˚), i.e., for ‘‘scoring’’ a given ligand
‘‘pose’’. The task of searching and ﬁnding the ligand pose, i.e.,
‘‘docking’’, is quite different and normally precedes scoring.
Although docking by MD can be done, this is clearly not the
most efﬁcient approach to accomplish this task. Extensive FEP/
MD calculations with very long trajectories amount essentially
to accomplishing both the docking and the scoring tasks
simultaneously. Ligand docking by extensive MD is certainly
feasible, thoughaccurate dockingmodelsmaybegenerated at a
lesser computational cost with heuristic methods. The concept
of scoring a particular ligand pose from FEP/MDmakes sense
only if rapid interconversion to neighboring poses (assuming
they exist) is prevented by energy barriers of several kBT (i.e.,
they are essential different binding sites). If such condition is
notmet, then the truebinding free energymust beobtainedvia a
sampling over all the substatewith properweighting.While the
present step-by-step formulation could be used advantageously
with extensively longFEP/MDsimulations,webelieve that it is
most useful when used in conjunction with accurate starting
conﬁgurations, obtained either from x-ray crystallography or
high-quality docking models.
CONCLUSION
The standard binding free energy of eight FK506-related
ligands of FKBP12 was calculated using a FEP/MD
simulation protocol incorporating the effect of full atomic
ﬂexibility and thermal ﬂuctuations. The results are generally
in good accord with experiments and the extensive calcu-
lations of Pande and co-workers (63) and Shirts (64). When
the starting structure is taken from x-ray crystallography, the
calculated binding free energy is usually in good agreement
with the experimental results (within 2 kcal/mol) and the
statistical error is small (;1 kcal/mol). Given that the
program and method used are signiﬁcantly different
from those used by Pande and co-workers (63), we con-
sider the agreement satisfactory. On the other hand, if the
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initial complex structure is a modeled structure, the calcu-
lated binding free energy may be less precise. This highlights
the importance of accurate docking to enable a success-
ful rapid evaluation of the binding free energy with FEP/MD.
A number of features were implemented to enhance the
accuracy of the results while reducing the overall computa-
tional cost of the calculations. First, the reversible work for
the entire association/dissociation process was decomposed
into eight sequential steps duringwhich the ligand-surrounding
interactions as well as various biasing potentials restraining
the ligand are turned ‘‘on’’ and ‘‘off’’. The usage of those
biasing potentials decreases the size of the conﬁgurational
space that needs to be explored, therefore reducing the sam-
pling workload of the FEP/MD simulations. The advantage is
noise reduction, which leads to a more rapid convergence of
the computations. Second, a RMSD umbrella sampling PMF
calculations was used to accurately sample the conformation
of the ligand in the binding and in the bulk. Effectively, the
RMSD restraining potential enables us to transform a ﬂexible
ligand into a relatively rigid molecule, which simpliﬁes all the
subsequent steps considerably. One may note that a similar
RMSD potential could be easily extended to restrain a ﬂexible
protein receptor as well. Third, the convergence of the cal-
culation of the nonbond interaction free energy contribution
was improved by separating the LJ potential into a repulsive
and dispersive free energy using WCA. This separation also
allows a clear identiﬁcation of the molecular components
contributing favorably to the binding. Fourth, only a small
number of atoms in the vicinity of the binding site were
explicitly simulated with GSBP while the inﬂuence of the
remaining atoms was incorporated implicitly. This allowed a
signiﬁcant reduction in the size of the simulated systems, from
;25,000 to 2500 atoms.
Throughout the discussion, a number of observations were
made concerning the physical meaning of various free
energy contributions upon ligand binding, such as the loss of
translational, orientational, and conformational freedom, as
well as the changes in repulsive, dispersive, and electrostatic
nonbonded interactions. Although the mathematical deﬁni-
tion of all these contributions is unambiguous, it is important
to recall that their precise numerical values depend on the
choices of applied restraint potentials. Similarly, the free
energy components arising from the separation of the
nonbonded interactions (WCA-LJ and partial charge elec-
trostatics) are well-deﬁned, but nonetheless reﬂect a series of
choices about hypothetical intermediate states. Ultimately,
only the total absolute free energy is invariant and indepen-
dent of all those choices. In trying to attribute a physical
meaning to the various contributions, it is therefore impor-
tant to keep these limitations in mind. Only a careful and
judicious analysis of the various components can yield
physically meaningful insight. The best is to utilize the free
energy decomposition to highlight qualitative concepts, such
as, for example, the general importance of the loss of trans-
lational and orientation freedom on the total binding free en-
ergy, the magnitude of the free energy cost to restrict the
ligand into its bound conformation, and the relative change
in the nonbonded interactions upon binding. For example, an
important qualitative observation from the series of compu-
tations is that the dispersive interaction is an important driving
force for complexation. In other words, isosteric nonpolar
analogs of these ligands (without any partial charges) would
still bind (assuming that their internal conformation would
be unchanged). This observation arises naturally from the
free energy decomposition used here to separate the various
contributions to the nonbonded interactions (repulsion, dis-
persion, and electrostatics).
The step-by-step computational FEP/MD simulation pro-
tocol with restraining potential breaks down the complete
calculation into many short MD simulations that are easy to
distribute over independent compute nodes. This makes it
possible to use trivially distributed computing resources for
direct calculations of standard binding free energy. For each
ligand system, ;250 MD trajectories systems were gener-
ated, each taking ;2–4 h using a single 1-GHz Pentium
CPU. Thus, the total computational time to obtain the stan-
dard binding free energy of one ligand can be as little as 2–4
h, if 250 CPUs are available simultaneously. The various
biasing restraints help reduce the noise and improve the
convergence of the ﬁnal results. At this point, it seems clear
the ultimate limitations of calculated standard binding free
energies is not the statistical precision that can be achieved.
Whenever necessary, a higher precision could be obtained at
reasonable computational cost simply by increasing the length
and the number of simulations. Furthermore, it should be
noted that while simulating a reduced GSBP atomic model
may often be advantageous, such solvent boundary poten-
tials remain approximate. If a better representation of the
entire molecular system is warranted, the same step-by-step
binding free energy formulationwith restraint potentials could
be used in extensive all-atom FEP/MD simulations with
periodic boundary conditions. One area where there remains
ample room for improvement concerns the atomic force
ﬁelds. Without being overly pessimistic, it seems likely that
no miraculous accuracy should be expected from simple
nonpolarizable ﬁxed-charges potential function (52). Quan-
titative accuracy (i.e.,.0.5 kcal/mol) might only be possible
by including the inﬂuence of induced polarization explicitly.
With these advances in FEP/MD methodologies, it is clear
that improved force ﬁelds could enable rapid predictive bind-
ing estimates of quantitative accuracy at a very reasonable
computational cost for rational drug design.
APPENDIX A
In the expressions in Table A1,U1 is the total potential energy of the system,
andU0 is the total potential energy of an intermediate state inwhich the ligand
does not interact with its surrounding (protein and/or solvent). The
conformational, translational, and orientational biasing potentials are uc, ut,
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and ur respectively. Because the ligand molecule does not interact with its
surrounding with potentialU0, the orientational factor Fr in Step 5 is given by
Fr ¼
R
dVLe
burðVLÞR
dVL
: (16)
where VL are the three angles deﬁning rigid body rotation of the ligand
molecule (relative to the receptor); the volume element implicitly includes a
Jacobian for the rotation angles. Similarly, the translational factor Ft in Step
6 is given by
Ft ¼
Z
drLe
butðrLÞ (17)
(all other terms cancel out). The translational factor Ft, hence the binding
constant Kb, has the dimension of volume (with a natural unit of A˚
3 in
atomistic simulations). The standard equilibrium binding constant is Kb and
the standard binding free energy is DGbind. C is the standard state con-
centration (equal to 1 M or 1/1661 A˚3).
APPENDIX B
As used in Table B1, the units of energy and distance used in GROMACS are
kJ/mol and nm,while they are kcal/mol and A˚ in CHARMM.The subscripts c
and g (e.g., as in kc and kg) mean CHARMM and GROMACS, respectively.
F(¼ 1/4.184kcal/kJ) is a conversion factor. In GROMACS format, Ryckaert-
Bellemans (RB) dihedral energy can be expressed using the parameters kn and
fn (n ¼ 0–5), which are converted from the parameters Cn as
U ¼ C0  C1cosf1C2cos2f C3cos3f
1C4cos
4
f C5cos5f
¼ C01 1
2
C21
3
8
C4
 
1 C1  3
4
C3  5
8
C5
 
cosf
1
1
2
C21
1
2
C4
 
cos2f1 1
4
C3  5
16
C5
 
cos3f
1
1
8
C4
 
cos4f1  1
16
C5
 
cos5f
¼ +
5
n¼1
kn1 +
5
n¼1
kncosðnf fnÞ; (18)
where fn ¼ 0 or 180.
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TABLE B1 Conversion of AMBER force ﬁeld from GROMACS to CHARMM format
Conversion
GROMACS Energy CHARMM Energy para1 para2
Bond: 1
2
kðb b0Þ2 k(b  b0)2 kc ¼ (0.5/100)Fkg bc ¼ 10 bg
Angle: 1
2
kðu u0Þ2 k(u  u0)2 kc ¼ 0.5 Fkg uc ¼ ug
NB: eðð21=6s
r
Þ12  2ð21=6s
r
Þ6Þ eðð2s
r
Þ12  2ðs
r
Þ6Þ ec ¼ Feg sc ¼ ð21=6310=2Þsg
Dihe: k 1 kcos(nf  f0) k 1 kcos(nf  f0) kc ¼ Fkg fc ¼ fg
RB Dihe: +5
1
kn1+
5
1
kncosðnf fnÞ +51kn1+51kncosðnf fnÞ kn, c ¼ Fkn, g fn, c ¼ fn, g
TABLE A1 Decomposition of the binding process in eight steps
Step Process Conﬁgurational integral Contribution
1 ðLRÞaq ðLcRÞaq
R
site
dðLÞ
R
dðXÞebU1R
site
dðLÞ
R
dðXÞeb½U11uc  e
bDGsitec
2 ðLcRÞaq ðLc   transRÞaq
R
site
dðLÞ
R
dðXÞeb½U11uc R
site
dðLÞ
R
dðXÞeb½U11uc1ut  e
bDGsitet
3 ðLc   transRÞaq ðLc      transrotRÞaq
R
site
dðLÞ
R
dðXÞeb½U11uc1ut R
site
dðLÞ
R
dðXÞeb½U11uc1ut1ur  e
bDGsiter
4 ðLc      transrotRÞaqLc;vac      transrot½Raq
R
site
dðLÞ
R
dðXÞeb½U11uc1ut1ur R
site
dðLÞ
R
dðXÞeb½U01uc1ut1ur  e
bDGsiteint
5 Lc;vac      transrot½RaqLc;vac   trans½Raq
R
dðLÞ
R
dðXÞeb½U01uc1ut1ur R
dðLÞ
R
dðXÞeb½U01uc1ut  Fr
6 Lc;vac   trans½RaqLc;vac1½Raq
R
dðLÞdðrLrÞ
R
dðXÞeb½U01uc1ut R
dðLÞ
R
dðXÞeb½U01uc  Ft
7 Lc;vacLc;aq
R
bulk
dðLÞdðrLrÞ
R
dðXÞeb½U01uc R
bulk
dðLÞdðrLrÞ
R
dðXÞeb½U11uc  e
bDGbulkint
8 Lc;aqLaq
R
bulk
dðLÞdðrLrÞ
R
dðXÞeb½U11uc R
bulk
dðLÞdðrLrÞ
R
dðXÞebU1 e
bDGbulkc
Total K+b [ e
bDG+bind ¼ C+FtFreb½DGsitec DGsitet DGsiter 1DGsiteint DGbulkint 1DGbulkc 
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